Holger Schmidt’s lab develops unique, highly sensitive devices to detect pathogen biomarkers.
CREDIT: Nick Gonzales
Sophisticated systems for the detection of biomarkers — molecules such as DNA or proteins that indicate the presence of a disease — are crucial for real-time diagnostic and disease-monitoring devices.
Holger Schmidt, distinguished professor of electrical and computer engineering at UC Santa Cruz, and his group have long been focused on developing unique, highly sensitive devices called optofluidic chips to detect biomarkers.
Schmidt’s graduate student Vahid Ganjalizadeh led an effort to use machine learning to enhance their systems by improving its ability to accurately classify biomarkers. The deep neural network he developed classifies particle signals with 99.8 percent accuracy in real time, on a system that is relatively cheap and portable for point-of-care applications, as shown in a new paper in Nature Scientific Reports.
When taking biomarker detectors into the field or a point-of-care setting such as a health clinic, the signals received by the sensors may not be as high quality as those in a lab or a controlled environment. This may be due to a variety of factors, such as the need to use cheaper chips to bring down costs, or environmental characteristics such as temperature and humidity.
To address the challenges of a weak signal, Schmidt and his team developed a deep neural network that can identify the source of that weak signal with high confidence. The researchers trained the neural network with known training signals, teaching it to recognize potential variations it could see, so that it can recognize patterns and identify new signals with very high accuracy.
First, a parallel cluster wavelet analysis (PCWA) approach designed in Schmidt’s lab detects that a signal is present. Then, the neural network processes the potentially weak or noisy signal, identifying its source. This system works in real time, so users are able to receive results in a fraction of a second.
“It’s all about making the most of possibly low quality signals, and doing that really fast and efficiently,” Schmidt said.
A smaller version of the neural network model can run on portable devices. In the paper, the researchers run the system over a Google Coral Dev board, a relatively cheap edge device for accelerated execution of artificial intelligence algorithms. This means the system also requires less power to execute the processing compared to other techniques.
“Unlike some research that requires running on supercomputers to do high-accuracy detection, we proved that even a compact, portable, relatively cheap device can do the job for us,” Ganjalizadeh said. “It makes it available, feasible, and portable for point-of-care applications.”
The entire system is designed to be used completely locally, meaning the data processing can happen without internet access, unlike other systems that rely on cloud computing. This also provides a data security advantage, because results can be produced without the need to share data with a cloud server provider.
It is also designed to be able to give results on a mobile device, eliminating the need to bring a laptop into the field.
“You can build a more robust system that you could take out to under-resourced or less- developed regions, and it still works,” Schmidt said.
This improved system will work for any other biomarkers Schmidt’s lab’s systems have been used to detect in the past, such as COVID-19, Ebola, flu, and cancer biomarkers. Although they are currently focused on medical applications, the system could potentially be adapted for the detection of any type of signal.
To push the technology further, Schmidt and his lab members plan to add even more dynamic signal processing capabilities to their devices. This will simplify the system and combine the processing techniques needed to detect signals at both low and high concentrations of molecules. The team is also working to bring discrete parts of the setup into the integrated design of the optofluidic chip.
Original Article: Deep neural network provides robust detection of disease biomarkers in real time
More from: University of California Santa Cruz
The Latest Updates from Bing News
Go deeper with Bing News on:
Real-time diagnostic device
- Samsung Acquires French AI Firm Sonio to Advance Medical Diagnostic Systems
Samsung Electronics‘ medical equipment unit, Samsung Medison, is dedicated to creating diagnostic imagining devices. On Wednesday, Samsung announced that it plans to acquire Sonio, a Paris-based ...
- Samsung Medison to acquire French AI ultrasound startup Sonio for $92.7M
Samsung Medison, a medical device unit of Samsung Electronics that specializes ... a product that uses deep learning algorithms to improve the image quality of ultrasound scans in real time. Samsung ...
- Samsung Set to Buy French AI Company as It Looks to Advance Medical Diagnostic Systems
Samsung has announced its intention to acquire Sonio, a French artificial intelligence company, as part of its strategy to enhance its medical diagnostic systems. The use of AI technology has grown ...
- A diagnostic tool for ‘forgotten’ disease of endometriosis
EndoCure is combining ultrasound and AI to allow physicians to clearly see the tiny lesions invisible to standard imaging systems – a tool that could transform diagnosis.
- Fusion record set for tungsten tokamak WEST
Princeton Plasma Physics Laboratory (PPPL) measured a new record for a fusion device internally clad in tungsten, the element that could be the best fit for the commercial-scale machines required to ...
Go deeper with Bing News on:
Biomarker detectors
- Best Carbon Monoxide Detector for 2024
He is in charge of developing and carrying out testing procedures for a wide variety of home appliances and smart devices including robot vacuums, smoke/CO detectors and air conditioning units.
- Proteomic Approaches in Lung Cancer Biomarker Development
However, if there is an available biomarker for tumor assessment prior to biopsy, those biomarkers from other sources would be valuable. Furthermore, given that the ultimate goal of discovering a ...
- Letter to the editor: Support biomarker Senate Bill
This month, volunteers for the American Cancer Society Cancer Action Network from all across Pennsylvania will meet with their lawmakers in Harrisburg to advocate for improved access to biomarker ...
- Everything You Need to Know About AI Detectors for ChatGPT
AI detectors are more likely to falsely label written content from someone whose first language isn’t English as AI than that from someone who’s a native speaker. As developers continue to ...
- Best Smoke Detector for 2024
He is in charge of developing and carrying out testing procedures for a wide variety of home appliances and smart devices including robot vacuums, smoke/CO detectors and air conditioning units.